• 1. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 4. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 5. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220

Phenyl 6-Chloro-5-methoxypicolinate (CAS No. 204378-35-8): An Overview of Its Properties and Applications

Phenyl 6-chloro-5-methoxypicolinate (CAS No. 204378-35-8) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique molecular structure, has garnered attention for its potential therapeutic properties and its role in the development of novel drugs. In this article, we will delve into the chemical properties, synthesis methods, and recent research findings related to Phenyl 6-chloro-5-methoxypicolinate.

Chemical Structure and Properties

Phenyl 6-chloro-5-methoxypicolinate is a derivative of picolinic acid, featuring a phenyl group, a chlorine atom, and a methoxy group attached to the picolinic acid scaffold. The molecular formula of this compound is C₁₄H₁₁ClNO₃, with a molecular weight of approximately 278.7 g/mol. The presence of these functional groups imparts unique chemical properties to the molecule, making it an interesting candidate for various chemical and biological studies.

The compound exhibits good solubility in organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF), which facilitates its use in solution-based reactions and biological assays. Additionally, the presence of the methoxy group enhances the lipophilicity of the molecule, potentially improving its cell membrane permeability and bioavailability.

Synthesis Methods

The synthesis of Phenyl 6-chloro-5-methoxypicolinate can be achieved through several routes, each with its own advantages and limitations. One common method involves the esterification of 6-chloro-5-methoxypicolinic acid with phenol in the presence of a coupling agent such as dicyclohexylcarbodiimide (DCC) or 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC·HCl). This reaction typically proceeds under mild conditions and yields high purity products.

An alternative approach involves the reaction of phenol with 6-chloro-5-methoxypicolinoyl chloride in an appropriate solvent. This method is often preferred due to its simplicity and higher yield. The choice of synthesis route depends on factors such as the availability of starting materials, reaction conditions, and desired product purity.

Biological Activity and Therapeutic Potential

Phenyl 6-chloro-5-methoxypicolinate has been studied for its potential biological activities, particularly in the context of medicinal chemistry. Recent research has highlighted its anti-inflammatory and anti-cancer properties, making it a promising candidate for drug development.

In vitro studies have shown that Phenyl 6-chloro-5-methoxypicolinate exhibits significant anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). These findings suggest that the compound may have therapeutic potential in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Furthermore, preliminary studies have indicated that Phenyl 6-chloro-5-methoxypicolinate possesses anti-cancer properties by inducing apoptosis in cancer cells. Specifically, it has been shown to inhibit the growth of human breast cancer cells (MCF-7) and colon cancer cells (HT-29) by disrupting cell cycle progression and inducing DNA damage. These results warrant further investigation into the compound's potential as an anticancer agent.

Clinical Trials and Future Directions

The promising preclinical findings associated with Phenyl 6-chloro-5-methoxypicolinate have paved the way for clinical trials to evaluate its safety and efficacy in humans. While no large-scale clinical trials have been conducted yet, several Phase I trials are currently underway to assess the pharmacokinetics and tolerability of the compound in healthy volunteers.

The results from these initial trials will provide valuable insights into the dosing regimens and potential side effects associated with Phenyl 6-chloro-5-methoxypicolinate. If these trials demonstrate favorable outcomes, subsequent Phase II and III trials will be necessary to confirm its therapeutic benefits in specific patient populations.

In addition to clinical trials, ongoing research is focused on optimizing the chemical structure of Phenyl 6-chloro-5-methoxypicolinate to enhance its pharmacological properties. This includes efforts to improve its solubility, stability, and bioavailability through structural modifications or formulation strategies.

Conclusion

Phenyl 6-chloro-5-methoxypicolinate (CAS No. 204378-35-8) is a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure endows it with valuable properties such as good solubility, lipophilicity, and biological activity. Recent studies have highlighted its potential as an anti-inflammatory and anti-cancer agent, warranting further investigation through clinical trials.

Ongoing research aims to optimize its chemical structure and evaluate its safety and efficacy in humans. As these efforts progress, Phenyl 6-chloro-5-methoxypicolinate may emerge as a valuable therapeutic option for treating various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)